# Comparing the Efficacy and Safety of Rosuvastatin With Atorvastatin and Simvastatin (SOLAR)

> **NCT00654173** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 4444 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** Rosuvastatin
- **DRUG:** Simvastatin
- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT00654173
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06
- **Primary completion:** —
- **Final completion:** 2004-09
- **Target enrollment:** 4444 (ACTUAL)
- **Last updated:** 2009-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00654173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00654173, "Comparing the Efficacy and Safety of Rosuvastatin With Atorvastatin and Simvastatin (SOLAR)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00654173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*